Eat, Sleep, Console for Neonatal Abstinence Syndrome Babies [PDF]
, 2019 Neonatal Abstinence Syndrome (NAS) is a complex disorder that manifests with neurologic, gastrointestinal, and musculoskeletal disturbances and is most often associated with opioid withdrawal. In the US, 6 out of 1,000 babies are born to mothers who used
Patton, Kathryn
core +1 more source
Frontiers in Pediatrics, 2021 Objective: To investigate the outcomes associated with the implementation of a neonatal abstinence syndrome (NAS) treatment algorithm utilizing dual therapy with morphine sulfate and clonidine in a level four neonatal intensive care unit (NICU).Study ...
Mohammad Y. Bader +11 more
doaj +1 more source
Putting Families First: How the Opioid Epidemic is Affecting Children and Families, and the Child Welfare Policy Options to Address It [PDF]
, 2019 : Opioids and Child Welfare Across the country, placements in foster care are rising. In 2016, the U.S. Department of Health and Human Services reported that 273,539 children in the U.S. entered foster care.
American Academy of Pediatrics Council on Foster Care, Adoption, and Kinship Care +3 more
core +1 more source
Neonatal Abstinence Syndrome Due to Opioid Abuse in Pregnancy
Gynecology Obstetrics & Reproductive Medicine, 2018 Opioid abuse during pregnancy is increasing in women of childbearing age in Turkey. The frequency of clinical signs of withdrawal in infants who exposed to heroin in utero are varying between 16-90%.
Banu Mutlu Ozyurt +2 more
doaj +1 more source
Does Maternal Methadone Dose Correlate with Severity of Intrauterine Growth Restriction in Infants with Neonatal Abstinence Syndrome? [PDF]
, 2020 Introduction : Previous studies demonstrate a relationship between maternal opioid use during pregnancy and smaller head circumference of infants with neonatal abstinence syndrome (NAS).
Aghai, Z. H. +3 more
core +1 more source
Neonatal abstinence syndrome: an update [PDF]
Current Opinion in Pediatrics, 2018 Purpose of review The current review provides an update focused on the evolving epidemiology of neonatal abstinence syndrome (NAS), factors influencing disease expression, advances in clinical assessment of withdrawal, novel approaches to NAS treatment, and the emerging role of quality improvement in assessment and management ...
Lauren A, Sanlorenzo +2 more
openaire +2 more sources
Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
Children, 2021 Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure.
Miriam Moreno-Ramos +4 more
doaj +1 more source
Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers. [PDF]
, 2017 Background Neonatal abstinence syndrome (NAS) in infants of methadone-maintained opioid-dependent (MMOD) mothers cannot be predicted in individual cases. We investigated whether variation in infant genotype is associated with severity of NAS.
Gillis, C. +3 more
core +1 more source
Journal of Clinical and Translational Science, 2020 Objective: The objective of this study was to systematically assess the literature regarding postnatal healthcare utilization and barriers/facilitators of healthcare in neonatal abstinence syndrome (NAS) children.
Adam Van Horn +5 more
doaj +1 more source
As Opioid Use Climbs, Neonatal Abstinence Syndrome Rises in New Hampshire [PDF]
, 2017 In this brief, author Kristin Smith analyzes inpatient hospital discharge data (2012–2015) to assess the prevalence of neonatal abstinence syndrome (NAS) in New Hampshire; describes one hospital’s successful program for treating pregnant women and ...
Smith, Kristin
core +1 more source